Whereas co-occurring TP53 mutations are associated with inflammatory tumor microenvironment and higher levels of PD-L1 expression, STK11/LKB1 and KEAP1 mutations correlate with immunosuppressive tumor microenvironment and shorter survival [55,56]. Here, STK11 is linked to neoplasm.